167 related articles for article (PubMed ID: 22208965)
1. Local failure in resected N1 lung cancer: implications for adjuvant therapy.
Higgins KA; Chino JP; Berry M; Ready N; Boyd J; Yoo DS; Kelsey CR
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):727-33. PubMed ID: 22208965
[TBL] [Abstract][Full Text] [Related]
2. Failure rates and patterns of recurrence in patients with resected N1 non-small-cell lung cancer.
Varlotto JM; Medford-Davis LN; Recht A; Flickinger JC; Schaefer E; DeCamp MM
Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):353-9. PubMed ID: 20732754
[TBL] [Abstract][Full Text] [Related]
3. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
[TBL] [Abstract][Full Text] [Related]
4. Completely resected N1 non-small cell lung cancer: factors affecting recurrence and long-term survival.
Fujimoto T; Cassivi SD; Yang P; Barnes SA; Nichols FC; Deschamps C; Allen MS; Pairolero PC
J Thorac Cardiovasc Surg; 2006 Sep; 132(3):499-506. PubMed ID: 16935101
[TBL] [Abstract][Full Text] [Related]
5. Pathologic N1 non-small cell lung cancer: correlation between pattern of lymphatic spread and prognosis.
Marra A; Hillejan L; Zaboura G; Fujimoto T; Greschuchna D; Stamatis G
J Thorac Cardiovasc Surg; 2003 Mar; 125(3):543-53. PubMed ID: 12658196
[TBL] [Abstract][Full Text] [Related]
6. Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer.
Koike T; Koike T; Yoshiya K; Tsuchida M; Toyabe S
J Thorac Cardiovasc Surg; 2013 Aug; 146(2):372-8. PubMed ID: 23870323
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of visceral pleural invasion in resected non-small cell lung cancer diagnosed by using a jet stream of saline solution.
Maruyama R; Shoji F; Okamoto T; Miyamoto T; Miyake T; Nakamura T; Ikeda J; Asoh H; Yamaguchi M; Yoshino I; Ichinose Y
J Thorac Cardiovasc Surg; 2004 Jun; 127(6):1587-92. PubMed ID: 15173711
[TBL] [Abstract][Full Text] [Related]
8. Nodal stage of surgically resected non-small cell lung cancer and its effect on recurrence patterns and overall survival.
Varlotto JM; Yao AN; DeCamp MM; Ramakrishna S; Recht A; Flickinger J; Andrei A; Reed MF; Toth JW; Fizgerald TJ; Higgins K; Zheng X; Shelkey J; Medford-Davis LN; Belani C; Kelsey CR
Int J Radiat Oncol Biol Phys; 2015 Mar; 91(4):765-73. PubMed ID: 25752390
[TBL] [Abstract][Full Text] [Related]
9. An association between preoperative anemia and decreased survival in early-stage non-small-cell lung cancer patients treated with surgery alone.
Yovino S; Kwok Y; Krasna M; Bangalore M; Suntharalingam M
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1438-43. PubMed ID: 16029805
[TBL] [Abstract][Full Text] [Related]
10. Surgery and chemotherapy for small cell lung cancer in stages I-II with or without radiotherapy.
Bischof M; Debus J; Herfarth K; Muley T; Kappes J; Storz K; Hoffmann H
Strahlenther Onkol; 2007 Dec; 183(12):679-84. PubMed ID: 18040612
[TBL] [Abstract][Full Text] [Related]
11. Local recurrence after surgery for early stage lung cancer: an 11-year experience with 975 patients.
Kelsey CR; Marks LB; Hollis D; Hubbs JL; Ready NE; D'Amico TA; Boyd JA
Cancer; 2009 Nov; 115(22):5218-27. PubMed ID: 19672942
[TBL] [Abstract][Full Text] [Related]
12. Patterns of failure after resection of non-small-cell lung cancer: implications for postoperative radiation therapy volumes.
Kelsey CR; Light KL; Marks LB
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1097-105. PubMed ID: 16682136
[TBL] [Abstract][Full Text] [Related]
13. Lymphovascular invasion in non-small-cell lung cancer: implications for staging and adjuvant therapy.
Higgins KA; Chino JP; Ready N; D'Amico TA; Berry MF; Sporn T; Boyd J; Kelsey CR
J Thorac Oncol; 2012 Jul; 7(7):1141-7. PubMed ID: 22617241
[TBL] [Abstract][Full Text] [Related]
14. Skip mediastinal lymph node metastasis and lung cancer: a particular N2 subgroup with a better prognosis.
Riquet M; Assouad J; Bagan P; Foucault C; Le Pimpec Barthes F; Dujon A; Danel C
Ann Thorac Surg; 2005 Jan; 79(1):225-33. PubMed ID: 15620948
[TBL] [Abstract][Full Text] [Related]
15. Factors associated with local and distant recurrence and survival in patients with resected nonsmall cell lung cancer.
Varlotto JM; Recht A; Flickinger JC; Medford-Davis LN; Dyer AM; Decamp MM
Cancer; 2009 Mar; 115(5):1059-69. PubMed ID: 19152440
[TBL] [Abstract][Full Text] [Related]
16. Stage IB nonsmall cell lung cancers: are they all the same?
Jones DR; Daniel TM; Denlinger CE; Rundall BK; Smolkin ME; Wick MR
Ann Thorac Surg; 2006 Jun; 81(6):1958-62; discussion 1962. PubMed ID: 16731113
[TBL] [Abstract][Full Text] [Related]
17. Local failure after complete resection of N0-1 non-small cell lung cancer.
Saynak M; Veeramachaneni NK; Hubbs JL; Nam J; Qaqish BF; Bailey JE; Chung W; Marks LB
Lung Cancer; 2011 Feb; 71(2):156-65. PubMed ID: 20615576
[TBL] [Abstract][Full Text] [Related]
18. Preoperative chemotherapy versus preoperative chemoradiotherapy for stage III (N2) non-small-cell lung cancer.
Higgins K; Chino JP; Marks LB; Ready N; D'Amico TA; Clough RW; Kelsey CR
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1462-7. PubMed ID: 19467798
[TBL] [Abstract][Full Text] [Related]
19. Predictors of survival and disease-free survival in patients with resected N1 non-small cell lung cancer.
Cerfolio RJ; Bryant AS
Ann Thorac Surg; 2007 Jul; 84(1):182-8; discussion 189-90. PubMed ID: 17588408
[TBL] [Abstract][Full Text] [Related]
20. Results of primary surgery with T4 non-small cell lung cancer during a 25-year period in a single center: the benefit is worth the risk.
Yildizeli B; Dartevelle PG; Fadel E; Mussot S; Chapelier A
Ann Thorac Surg; 2008 Oct; 86(4):1065-75; discussion 1074-5. PubMed ID: 18805134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
